Duntas L, Grab B M, Dominguez-Munoz J E, Nelson D K, Loos U, Keck F S
Abteilung Innere Medizin I, Universität Ulm, Germany.
Horm Metab Res. 1993 Aug;25(8):430-3. doi: 10.1055/s-2007-1002138.
The recent introduction of third generation assays for TSH has led to a considerable improvement of assay sensitivity. To assess the clinical significance of subnormal basal TSH (b-TSH) values (< 0.2 microU/ml), we investigated b-TSH and TRH-stimulated TSH (r-TSH) by means of a new, highly sensitive immunochemiluminometric assay in 105 euthyroid subjects, 45 patients with overt hyperthyroidism and 18 patients suspected of having subclinical hyperthyroidism. A weak, albeit statistically significant, correlation (r = 0.48) was found between b-TSH and r-TSH and also between b-TSH and delta-TSH (r = 0.31) in euthyroid subjects. Consideration of b-TSH alone correctly identified 90 % of euthyroid subjects in this group; 10 of 105 apparently euthyroid subjects presented delta-TSH suggesting subclinical hyperthyroidism. While b-TSH was detectable (> 0.04 microU/ml) in 8 of 45 (18%) of hyperthyroid patients, all (100%) were abnormal in both b-TSH and r-TSH. 14 of 18 (78%) of patients with subclinical hyperthyroidism exhibited a blunted TSH response to stimulation (delta-TSH < 2 microU/ml). These results suggest that although the new generation of TSH assays can be a valuable addition to the diagnostic arsenal of thyroid function tests, certain limitations must still be accepted. Specifically, b-TSH in the "grey zone" (0.1-0.2 microU/ml) appears to be a less than reliable predictor of thyroid function.
第三代促甲状腺激素(TSH)检测方法的近期问世,使检测灵敏度有了显著提高。为评估基础促甲状腺激素(b-TSH)值低于正常范围(<0.2微国际单位/毫升)的临床意义,我们采用一种新型高灵敏度免疫化学发光分析法,对105例甲状腺功能正常的受试者、45例显性甲状腺功能亢进患者和18例疑似亚临床甲状腺功能亢进患者的b-TSH和促甲状腺激素释放激素(TRH)刺激后的促甲状腺激素(r-TSH)进行了研究。在甲状腺功能正常的受试者中,b-TSH与r-TSH之间以及b-TSH与促甲状腺激素变化值(delta-TSH)之间存在微弱但具有统计学意义的相关性(r = 0.48)和(r = 0.31)。仅考虑b-TSH可正确识别该组中90%的甲状腺功能正常的受试者;105例看似甲状腺功能正常的受试者中有10例出现促甲状腺激素变化值,提示亚临床甲状腺功能亢进。虽然45例(18%)甲状腺功能亢进患者中有8例可检测到b-TSH(>0.04微国际单位/毫升),但所有患者(100%)的b-TSH和r-TSH均异常。18例亚临床甲状腺功能亢进患者中有14例(78%)对刺激的促甲状腺激素反应减弱(促甲状腺激素变化值<2微国际单位/毫升)。这些结果表明,尽管新一代促甲状腺激素检测方法是甲状腺功能检测诊断手段中的一项有价值补充,但仍必须接受某些局限性。具体而言,处于“灰色区域”(0.1 - 0.2微国际单位/毫升)的b-TSH似乎是甲状腺功能的一个不太可靠的预测指标。